Enfortumab Vedotin Plus Pembrolizumab vs. Chemotherapy for Untreated la/mUC: EV-302 Study Update ASCO GU 3 Mins Read Dr. Thomas Powles, MBBS, MRCP, MD, from Barts Cancer Institute at Queen Mary University of Londonon February 17, 2025 At…
Encorafenib + cetuximab (EC) BREAKWATER Study Reveals Breakthrough in Treating BRAF V600E-Mutant Metastatic Colorectal Cancer Gastrointestinal 3 Mins Read The latest findings from the BREAKWATER study, a phase 3 clinical trial, have shown significant strides in improving treatment outcomes…
Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024: AVEO Kidney 4 Mins Read AVEO Oncology, a subsidiary of LG Chem, has announced the acceptance of its Phase 3 TiNivo-2 trial for a Proffered…
